Latest news
2023 National Immunisation Program influenza vaccination – Early advice for vaccination providers
Vaccination against influenza (flu) continues to be important this year. Vaccination is our best defence against flu viruses.
Release of the Australian Government's response to the Review of COVID-19 Vaccine and Treatment Purchasing and Procurement
The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
Protecting Older Australians – COVID-19 Update 14 February 2023
In this issue: Message from the Ministers to Aged Care Providers, ATAGI advice on 2023 COVID-19 vaccine booster, Webinar – aged care COVID-19 update and more.
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.
ATAGI 2023 booster advice
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.
Changes to HPV vaccine dose schedule for young Australians
From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under.
Expressions of interest to join the Australian Technical Advisory Group on Immunisation
We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert.
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).
A message from Chief Nursing and Midwifery Officer Alison McMillan – October 2022
A newsletter from Chief Nursing and Midwifery Officer Alison McMillan with updates from the nursing and midwifery sector, some personal priorities and highlights, and an insight on what's happening across the Department of Health and Aged Care.
Last updated: